Meningitis (peds) - Revision history

Ostermayer at 17:16, 17 January 2026

2026-01-17T17:16:06Z

← Older revision		Revision as of 17:16, 17 January 2026
Line 1:		Line 1:
	{{~~Peds top~~}} ~~[[meningitis]]~~		{{PediatricPage\|meningitis}}
	==Background==		==Background==
	[[File:Meningitis-Epidemics-World-Map.png\|thumb\|Epidemic meningitis geographic distribution showing "meningitis belt."]]		[[File:Meningitis-Epidemics-World-Map.png\|thumb\|Epidemic meningitis geographic distribution showing "meningitis belt."]]

SMReel: /* Clinical Features */

2022-10-04T15:43:14Z

Clinical Features

← Older revision		Revision as of 15:43, 4 October 2022
Line 27:		Line 27:
	*Weak cry		*Weak cry
	*[[Hypoglycemia]]		*[[Hypoglycemia]]
			*Rash

	==Differential Diagnosis==		==Differential Diagnosis==

Rossdonaldson1: /* See Also */

2020-12-12T10:31:05Z

ClaireLewis: /* van de Beek D. et al. Advances in treatment of bacterial meningitis. Lancet. Nov 10 2012;380(9854):1693-702Kowalsky RH, Jaffe DM. "Bacterial Meningitis Post-PCV7: Declining Incidence and Treatment" Pediatric Emergency Care. June 2013. 29(6)758-766 */

2020-10-22T00:01:02Z

van de Beek D. et al. Advances in treatment of bacterial meningitis. Lancet. Nov 10 2012;380(9854):1693-702Kowalsky RH, Jaffe DM. "Bacterial Meningitis Post-PCV7: Declining Incidence and Treatment" Pediatric Emergency Care. June 2013. 29(6)758-766

← Older revision		Revision as of 00:01, 22 October 2020
Line 126:		Line 126:
	===<1 month old<ref>van de Beek D. et al. Advances in treatment of bacterial meningitis. Lancet. Nov 10 2012;380(9854):1693-702</ref><ref>Kowalsky RH, Jaffe DM. "Bacterial Meningitis Post-PCV7: Declining Incidence and Treatment" Pediatric Emergency Care. June 2013. 29(6)758-766</ref>===		===<1 month old<ref>van de Beek D. et al. Advances in treatment of bacterial meningitis. Lancet. Nov 10 2012;380(9854):1693-702</ref><ref>Kowalsky RH, Jaffe DM. "Bacterial Meningitis Post-PCV7: Declining Incidence and Treatment" Pediatric Emergency Care. June 2013. 29(6)758-766</ref>===
	{{Neonatal meningitis antibiotics}}		{{Neonatal meningitis antibiotics}}

	Per the AAP, ceftazidime 50mg/kg IV (q12hr for babies < 8 days of age and q8hr for >7 days old) is a reasonable alternative to cefotaxime, offering virtually the same coverage for enteric bacilli and is FDA approved for all age groups

	===> 1 month old<ref>van de Beek D. et al. Advances in treatment of bacterial meningitis. Lancet. Nov 10 2012;380(9854):1693-702</ref>===		===> 1 month old<ref>van de Beek D. et al. Advances in treatment of bacterial meningitis. Lancet. Nov 10 2012;380(9854):1693-702</ref>===

Krca242 at 04:06, 25 September 2020

2020-09-25T04:06:40Z

← Older revision		Revision as of 04:06, 25 September 2020
Line 126:		Line 126:
	===<1 month old<ref>van de Beek D. et al. Advances in treatment of bacterial meningitis. Lancet. Nov 10 2012;380(9854):1693-702</ref><ref>Kowalsky RH, Jaffe DM. "Bacterial Meningitis Post-PCV7: Declining Incidence and Treatment" Pediatric Emergency Care. June 2013. 29(6)758-766</ref>===		===<1 month old<ref>van de Beek D. et al. Advances in treatment of bacterial meningitis. Lancet. Nov 10 2012;380(9854):1693-702</ref><ref>Kowalsky RH, Jaffe DM. "Bacterial Meningitis Post-PCV7: Declining Incidence and Treatment" Pediatric Emergency Care. June 2013. 29(6)758-766</ref>===
	{{Neonatal meningitis antibiotics}}		{{Neonatal meningitis antibiotics}}

			Per the AAP, ceftazidime 50mg/kg IV (q12hr for babies < 8 days of age and q8hr for >7 days old) is a reasonable alternative to cefotaxime, offering virtually the same coverage for enteric bacilli and is FDA approved for all age groups

	===> 1 month old<ref>van de Beek D. et al. Advances in treatment of bacterial meningitis. Lancet. Nov 10 2012;380(9854):1693-702</ref>===		===> 1 month old<ref>van de Beek D. et al. Advances in treatment of bacterial meningitis. Lancet. Nov 10 2012;380(9854):1693-702</ref>===

Rossdonaldson1 at 23:36, 28 November 2019

2019-11-28T23:36:22Z

← Older revision		Revision as of 23:36, 28 November 2019
Line 1:		Line 1:
	~~''This page is for <u>pediatric</u> meningitis. See~~ [[meningitis]] ~~for the adult page.''~~		{{Peds top}} [[meningitis]]
	==Background==		==Background==
	[[File:Meningitis-Epidemics-World-Map.png\|thumb\|Epidemic meningitis geographic distribution showing "meningitis belt."]]		[[File:Meningitis-Epidemics-World-Map.png\|thumb\|Epidemic meningitis geographic distribution showing "meningitis belt."]]

ClaireLewis at 18:19, 6 October 2019

2019-10-06T18:19:54Z

← Older revision		Revision as of 18:19, 6 October 2019
Line 49:		Line 49:
	#Chem		#Chem
	#Blood culture		#Blood culture
	#?CT head: See [[CT Before Lumbar Puncture]]		#?[[head CT\|CT head]]: See [[CT Before Lumbar Puncture]]
	#[[CXR]] (50% of patients with [[~~pneumoccocal~~]] meningitis have evidence of pneumonia on CXR)		#[[CXR]] (50% of patients with [[pneumococcal]] meningitis have evidence of pneumonia on CXR)
	#[[Lumbar Puncture]]		#[[Lumbar Puncture]]

Line 135:		Line 135:
	\| align="center" style="background:#f0f0f0;"\|'''Therapy'''		\| align="center" style="background:#f0f0f0;"\|'''Therapy'''
	\|-		\|-
	\| Basilar skull fracture\|\|[[Vancomycin]] + third-generation [[cephalosporin]]		\| [[Basilar skull fracture]]\|\|[[Vancomycin]] + third-generation [[cephalosporin]]
	\|-		\|-
	\| Penetrating trauma or recent neurosurgery\|\|[[Vancomycin]] + [[cefepime]], [[ceftazidime]], or [[meropenem]]		\| Penetrating trauma or recent neurosurgery\|\|[[Vancomycin]] + [[cefepime]], [[ceftazidime]], or [[meropenem]]
	\|-		\|-
	\| Ventricular shunt\|\|[[Vancomycin]] alone; if Gram stain reveals presence of gram-negative bacilli, then add [[cefepime]], [[ceftazidime]], or [[meropenem]]		\| [[VP shunt\|Ventricular shunt]]\|\|[[Vancomycin]] alone; if Gram stain reveals presence of gram-negative bacilli, then add [[cefepime]], [[ceftazidime]], or [[meropenem]]
	\|}		\|}

ClaireLewis at 03:50, 3 October 2019

2019-10-03T03:50:32Z

← Older revision		Revision as of 03:50, 3 October 2019
Line 15:		Line 15:
	[[File:Charlotte Cleverley-Bisman Meningicoccal Disease.jpg\|thumb\|Severe [[meningococcal]] meningitis with classic petechial rash progressing to gangrene.]]		[[File:Charlotte Cleverley-Bisman Meningicoccal Disease.jpg\|thumb\|Severe [[meningococcal]] meningitis with classic petechial rash progressing to gangrene.]]
	Following features in the correct clinical context should raise suspicion		Following features in the correct clinical context should raise suspicion
	*Fever		*[[Fever (Peds)\|Fever]], [[hypothermia]]
	*Headache		*[[headache (peds)\|Headache]]
	*Meningeal signs		*Meningeal signs
	*Poor feeding		*Poor feeding
	*Irritability		*Irritability
	*Apnea		*Apnea
	*Lethargy		*[[Lethargy]]
	*~~Fever~~		*[[Seizure (peds)\|Seizures]]
	*Hypothermia
	*Seizures
	*[[Bulging_Fontanelle\|Bulging fontanelle]]		*[[Bulging_Fontanelle\|Bulging fontanelle]]
	*Hypotonia		*Hypotonia
Line 157:		Line 155:
	[[Category:ID]]		[[Category:ID]]
	[[Category:Neurology]]		[[Category:Neurology]]
			[[Category:Pediatrics]]

Rossdonaldson1: /* Background */

2019-07-20T10:05:41Z

Background

← Older revision		Revision as of 10:05, 20 July 2019
Line 1:		Line 1:
	''This page is for <u>pediatric</u> meningitis. See [[meningitis]] for the adult page.''		''This page is for <u>pediatric</u> meningitis. See [[meningitis]] for the adult page.''
	==Background==		==Background==
			[[File:Meningitis-Epidemics-World-Map.png\|thumb\|Epidemic meningitis geographic distribution showing "meningitis belt."]]
	*Meningismus is difficult to discern if <6mo, (esp if <2mo)		*Meningismus is difficult to discern if <6mo, (esp if <2mo)
	*<3months old		*<3months old

Rossdonaldson1: /* Clinical Features */

2019-07-20T10:03:02Z

Clinical Features

← Older revision		Revision as of 10:03, 20 July 2019
Line 12:		Line 12:

	==Clinical Features==		==Clinical Features==
	[[File:Charlotte Cleverley-Bisman Meningicoccal Disease.jpg\|thumb\|]]		[[File:Charlotte Cleverley-Bisman Meningicoccal Disease.jpg\|thumb\|Severe [[meningococcal]] meningitis with classic petechial rash progressing to gangrene.]]
	Following features in the correct clinical context should raise suspicion		Following features in the correct clinical context should raise suspicion
	*Fever		*Fever

← Older revision		Revision as of 10:31, 12 December 2020
Line 150:		Line 150:
	==See Also==		==See Also==
	*[[Meningitis]]		*[[Meningitis]]
			*[[Neoplastic meningitis]]

	==References==		==References==